Fibroblast growth factor receptor 1 is a key inhibitor of TGFb signaling in the endothelium

Science Signaling

Volumn 7, Issue 344, 2014, Pages ra90-

  Chen, Pei Yu ^a   Qin, Lingfeng ^a   Tellides, George ^a   Simons, Michael ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 3; FIBROBLAST GROWTH FACTOR RECEPTOR 4; KLOTHO PROTEIN; MESSENGER RNA; SHORT HAIRPIN RNA; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; FGFR1 PROTEIN, HUMAN; FGFR1 PROTEIN, MOUSE; FIBROBLAST GROWTH FACTOR RECEPTOR; MICRORNA; MIRNLET7 MICRORNA, HUMAN; SMAD2 PROTEIN, HUMAN;

ABDOMINAL AORTA; ADULT; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CARDIAC GRAFT REJECTION; CONTROLLED STUDY; CORONARY ARTERY; EMBRYO; ENDOTHELIUM; ENDOTHELIUM CELL; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; FIBROBLAST; GENE INACTIVATION; GENE SILENCING; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NEOINTIMA; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; THORACIC AORTA; VASCULAR DISEASE; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL TRANSDIFFERENTIATION; CORONARY BLOOD VESSEL; CYTOLOGY; DEFICIENCY; GRAFT REJECTION; HINDLIMB; HISTOCOMPATIBILITY; ISCHEMIA; MESODERM; METABOLISM; MUTANT MOUSE STRAIN; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TRANSPLANTATION; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASCULARIZATION; XENOGRAFT;

ANIMALS; CELL TRANSDIFFERENTIATION; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; FIBROBLASTS; GRAFT REJECTION; HEART TRANSPLANTATION; HETEROGRAFTS; HINDLIMB; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; ISCHEMIA; MESODERM; MICE; MICE, MUTANT STRAINS; MICRORNAS; MUSCLE, SMOOTH, VASCULAR; NEOINTIMA; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTORS, FIBROBLAST GROWTH FACTOR; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANTATION CHIMERA;

EID: 84907512294     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2005504     Document Type: Article

References (39)

1. A. Beenken, M. Mohammadi, The FGF family: Biology, pathophysiology and therapy. Nat. Rev. Drug Discov. 8, 235-253 (2009)
2. B. Thisse, C. Thisse, Functions and regulations of fibroblast growth factor signaling during embryonic development. Dev. Biol. 287, 390-402 (2005)
3. M. Murakami, L. T. Nguyen, Z. W. Zhuang, K. L. Moodie, P. Carmeliet, R. V. Stan,M. Simons, The FGF system has a key role in regulating vascular integrity. J. Clin. Invest. 118, 3355-3366 (2008)
4. M. Murakami, L. T. Nguyen, K. Hatanaka, W. Schachterle, P. Y. Chen, Z. W. Zhuang, B. L. Black, M. Simons, FGF-dependent regulation of VEGF receptor 2 expression in mice. J. Clin. Invest. 121, 2668-2678 (2011)
5. K. Hatanaka, M. Simons, M. Murakami, Phosphorylation of VE-cadherin controls endothelial phenotypes via p120-catenin coupling and Rac1 activation. Am. J. Physiol. Heart Circ. Physiol. 300, H162-H172 (2011)
6. P. Y. Chen, L. Qin, C. Barnes, K. Charisse, T. Yi, X. Zhang, R. Ali, P. P. Medina, J. Yu, F. J. Slack, D. G. Anderson, V. Kotelianski, F. Wang, G. Tellides, M. Simons, FGF regulates TGF-b signaling and endothelial-to-mesenchymal transition via control of let-7 miRNA expression. Cell. Rep. 2, 1684-1696 (2012)
7. M. Murakami, M. Simons, Fibroblast growth factor regulation of neovascularization. Curr. Opin. Hematol. 15, 215-220 (2008)
8. M. Presta, P. Dell'Era, S. Mitola, E. Moroni, R. Ronca, M. Rusnati, Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev. 16, 159-178 (2005)
9. I. Lax, A. Wong, B. Lamothe, A. Lee, A. Frost, J. Hawes, J. Schlessinger, The docking protein FRS2a controls a MAP kinase-mediated negative feedback mechanism for signaling by FGF receptors. Mol. Cell 10, 709-719 (2002)
10. Y. R. Hadari, H. Kouhara, I. Lax, J. Schlessinger, Binding of Shp2 tyrosine phosphatase to FRS2 is essential for fibroblast growth factor-induced PC12 cell differentiation. Mol. Cell. Biol. 18, 3966-3973 (1998)
11. H. Kouhara, Y. R. Hadari, T. Spivak-Kroizman, J. Schilling, D. Bar-Sagi, I. Lax, J. Schlessinger, A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway. Cell 89, 693-702 (1997)
12. N. Gotoh, K. Manova, S. Tanaka, M. Murohashi, Y. Hadari, A. Lee, Y. Hamada, T. Hiroe, M. Ito, T. Kurihara, H. Nakazato, M. Shibuya, I. Lax, E. Lacy, J. Schlessinger, The docking protein FRS2a is an essential component of multiple fibroblast growth factor responses during early mouse development. Mol. Cell. Biol. 25, 4105-4116 (2005)
13. D. Givol, A. Yayon, Complexity of FGF receptors: Genetic basis for structural diversity and functional specificity. FASEB J. 6, 3362-3369 (1992)
14. C. X. Deng, A. Wynshaw-Boris, M. M. Shen, C. Daugherty, D. M. Ornitz, P. Leder, Murine FGFR-1 is required for early postimplantation growth and axial organization. Genes Dev. 8, 3045-3057 (1994)
15. T. P. Yamaguchi, K. Harpal, M. Henkemeyer, J. Rossant, fgfr-1 is required for embryonic growth and mesodermal patterning during mouse gastrulation. Genes Dev. 8, 3032-3044 (1994)
16. X. Xu, M. Weinstein, C. Li, M. Naski, R. I. Cohen, D. M. Ornitz, P. Leder, C. Deng, Fibroblast growth factor receptor 2 (FGFR2)-mediated reciprocal regulation loop between FGF8 and FGF10 is essential for limb induction. Development 125, 753-765 (1998)
17. V. P. Eswarakumar, J. Schlessinger, Skeletal overgrowth is mediated by deficiency in a specific isoform of fibroblast growth factor receptor 3. Proc. Natl. Acad. Sci. U.S.A. 104, 3937-3942 (2007)
18. M. Weinstein, X. Xu, K. Ohyama, C. X. Deng, FGFR-3 and FGFR-4 function cooperatively to direct alveogenesis in the murine lung. Development 125, 3615-3623 (1998)
19. S. S. Oladipupo, C. Smith, A. Santeford, C. Park, A. Sene, L. A. Wiley, P. Osei-Owusu, J. Hsu, N. Zapata, F. Liu, R. Nakamura, K. J. Lavine, K. J. Blumer, K. Choi, R. S. Apte, D. M. Ornitz, Endothelial cell FGF signaling is required for injury response but not for vascular homeostasis. Proc. Natl. Acad. Sci. U.S.A., 201324235 (2014)
20. M. S. Ridyard, S. M. Robbins, Fibroblast growth factor-2-induced signaling through lipid raft-associated fibroblast growth factor receptor substrate 2 (FRS2). J. Biol. Chem. 278, 13803-13809 (2003)
21. P. Krejci, B. Masri, L. Salazar, C. Farrington-Rock, H. Prats, L. M. Thompson,W. R.Wilcox, Bisindolylmaleimide I suppresses fibroblast growth factor-mediated activation of Erk MAP kinase in chondrocytes by preventing Shp2 association with the Frs2 and Gab1 adaptor proteins. J. Biol. Chem. 282, 2929-2936 (2007)
22. T.Yi, B. Fogal, Z. Hao, Z. Tobiasova,C.Wang,D. A. Rao, R. S.Al-Lamki, N. C. Kirkiles-Smith, S. Kulkarni, J. R. Bradley, A. L. Bothwell, W. C. Sessa, G. Tellides, J. S. Pober, Reperfusion injury intensifies the adaptive human T cell alloresponse in a human-mouse chimeric artery model. Arterioscler. Thromb. Vasc. Biol. 32, 353-360 (2012)
23. M. D. Muzumdar, B. Tasic, K. Miyamichi, L. Li, L. Luo, A global double-fluorescent Cre reporter mouse. Genesis 45, 593-605 (2007)
24. D. Tirziu, I. M. Jaba, P. Yu, B. Larrivée, B. G. Coon, B. Cristofaro, Z. W. Zhuang, A. A. Lanahan, M. A. Schwartz, A. Eichmann, M. Simons, Endothelial nuclear factor-kB-dependent regulation of arteriogenesis and branching. Circulation 126, 2589-2600 (2012)
25. D. M. Ornitz,N. Itoh,Fibroblast growth factors.Genome Biol. 2, reviews3005.1-reviews3005.12 (2001)
26. I. Urakawa, Y. Yamazaki, T. Shimada, K. Iijima, H. Hasegawa, K. Okawa, T. Fujita, S. Fukumoto, T. Yamashita, Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444, 770-774 (2006)
27. H. Kurosu, M. Choi, Y. Ogawa, A. S. Dickson, R. Goetz, A. V. Eliseenkova, M. Mohammadi, K. P. Rosenblatt, S. A. Kliewer, M. Kuro-o, Tissue-specific expression of bKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21. J. Biol. Chem. 282, 26687-26695 (2007)
28. E. Tkachenko, J. M. Rhodes, M. Simons, Syndecans: New kids on the signaling block. Circ. Res. 96, 488-500 (2005)
29. V. P. Eswarakumar, I. Lax, J. Schlessinger, Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev. 16, 139-149 (2005)
30. E. M. Zeisberg, O. Tarnavski, M. Zeisberg, A. L. Dorfman, J. R. McMullen, E. Gustafsson, A. Chandraker, X. Yuan, W. T. Pu, A. B. Roberts, E. G. Neilson, M. H. Sayegh, S. Izumo, R. Kalluri, Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat. Med. 13, 952-961 (2007)
31. E. Arciniegas, M. G. Frid, I. S. Douglas, K. R. Stenmark, Perspectives on endothelialto- mesenchymal transition: Potential contribution to vascular remodeling in chronic pulmonary hypertension. Am. J. Physiol. Lung Cell. Mol. Physiol. 293, L1-L8 (2007)
32. B. C. Cooley, J. Nevado, J. Mellad, D. Yang, C. St Hilaire, A. Negro, F. Fang, G. Chen, H. San, A. D. Walts, R. L. Schwartzbeck, B. Taylor, J.D. Lanzer, A. Wragg, A. Elagha, L. E. Beltran, C. Berry, R. Feil, R. Virmani, E. Ladich, J. C. Kovacic, M. Boehm, TGF-b signaling mediates endothelial-to-mesenchymal transition (EndMT) during vein graft remodeling. Sci. Transl. Med. 6, 227ra34 (2014)
33. L. Maddaluno, N. Rudini, R. Cuttano, L. Bravi, C. Giampietro, M. Corada, L. Ferrarini, F. Orsenigo, E. Papa, G. Boulday, E. Tournier-Lasserve, F. Chapon, C. Richichi, S. F. Retta, M. G. Lampugnani, E. Dejana, EndMT contributes to the onset and progression of cerebral cavernous malformations. Nature 498, 492-496 (2013)
34. M. Ginsberg, D. James, B. S. Ding, D. Nolan, F. Geng, J. M. Butler, W. Schachterle, V. R. Pulijaal, S. Mathew, S. T. Chasen, J. Xiang, Z. Rosenwaks, K. Shido, O. Elemento, S. Y. Rabbany, S. Rafii, Efficient direct reprogramming of mature amniotic cells into endothelial cells by ETS factors and TGFb suppression. Cell 151, 559-575 (2012)
35. N. Ricard, L. Tu, M. LeHiress, A. Huertas, C. Phan, R. Thuillet, C. Sattler, E. Fadel, A. Seferian, D. Montani, P. Dorfmüller, M. Humbert, C. Guignabert, Increased pericyte coverage mediated by endothelial derived fibroblast growth factor-2 and interleukin-6 is a source of smooth muscle-like cells in pulmonary hypertension. Circulation 129, 1586-1597 (2014)
36. D. R. Duncan, P. Y. Chen, J. T. Patterson, Y. U. Lee, N. Hibino, M. Cleary, Y. Naito, T. Yi, T. Gilliland, H. Kurobe, S. N. Church, T. Shinoka, T. M. Fahmy, M. Simons, C. K. Breuer, TGFbR1 inhibition blocks the formation of stenosis in tissue engineered vascular grafts. J. Am. Coll. Cardiol., in press (2014)
37. K. Mood, R. Friesel, I. O. Daar, SNT1/FRS2 mediates germinal vesicle breakdown induced by an activated FGF receptor1 in Xenopus oocytes. J. Biol. Chem. 277, 33196-33204 (2002)
38. X. Xu, W. Qiao, C. Li, C. X. Deng, Generation of Fgfr1 conditional knockout mice. Genesis 32, 85-86 (2002)
39. M. E. Pitulescu, I. Schmidt, R. Benedito, R. H. Adams, Inducible gene targeting in the neonatal vasculature and analysis of retinal angiogenesis in mice. Nat. Protoc. 5, 1518-1534 (2010)